V

Vernal Biosciences

56 employees

Vernal Biosciences specializes in high-purity mRNA for research and clinical use.

Basic info

Industry

biotechnology research

Sectors

mRNA manufacturing
Biotechnology
Life Science
mRNA design
Medical
mRNA therapeutics
mRNA vaccines

Date founded

2021

Funding rounds raised

Total raised

$21M

from 7 investors over 7 rounds

V

Vernal Biosciences raised $20M on June 27, 2023

Investors: Ampersand Capital Partners and VCET

V

Vernal Biosciences raised $21M on June 2, 2022

Investors: Ampersand Capital Partners, ATUM and Alloy Therapeutics, Inc

V

Vernal Biosciences raised undisclosed on July 12, 2021

Investors: VCET and Alloy Therapeutics, Inc

FAQ